Sebastian Kreuz

Director/Board Member at Abalos Therapeutics GmbH

Health Technology

Finance

Profile

Sebastian Kreuz has worked as a Director at Abalos Therapeutics GmbH and as an Investment Manager at Boehringer Ingelheim (Venture Capital) since 2019.

Sebastian Kreuz active positions

Companies	Position	Start
Abalos Therapeutics GmbH Abalos Therapeutics GmbH BiotechnologyHealth Technology Abalos Therapeutics GmbH engages in the development of an anti-cancer arenavirus-based drug. It focuses on awakening immune responses against tumors and metastases. The company was founded by Karl Lang and Philipp Lang and is headquartered in Essen, Germany.	Director/Board Member	-
Boehringer Ingelheim (Venture Capital) Boehringer Ingelheim (Venture Capital) Investment ManagersFinance Boehringer Ingelheim (BIVF) is the venture capital arm of Boehringer Ingelheim International GmbH, itself a subsidiary of C.H. Boehringer Sohn AG & Co. KG. The firm was founded in 2010 and is headquartered in Ingelheim, Germany. It also has two US offices located in Fremont, California, and Cambridge, Massachusetts.	Private Equity Investor	2019-05-31

All active positions of Sebastian Kreuz

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sebastian Kreuz's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Abalos Therapeutics GmbH Abalos Therapeutics GmbH BiotechnologyHealth Technology Abalos Therapeutics GmbH engages in the development of an anti-cancer arenavirus-based drug. It focuses on awakening immune responses against tumors and metastases. The company was founded by Karl Lang and Philipp Lang and is headquartered in Essen, Germany.	Health Technology
Boehringer Ingelheim (Venture Capital) Boehringer Ingelheim (Venture Capital) Investment ManagersFinance Boehringer Ingelheim (BIVF) is the venture capital arm of Boehringer Ingelheim International GmbH, itself a subsidiary of C.H. Boehringer Sohn AG & Co. KG. The firm was founded in 2010 and is headquartered in Ingelheim, Germany. It also has two US offices located in Fremont, California, and Cambridge, Massachusetts.	Finance